Report Published: "Taiwan Pharmaceuticals & Healthcare Report Q1 2014"
Taiwan's ageing population continues to be a key driver of pharmaceutical sales in the country. However, while the increase in premium collection resulted in a strong balance sheet for the National Health Insurance (NHI) scheme, it runs a risk of returning to deficit, as it is difficult to assess the actual medical demand for the ageing population. Moreover, as the population contracts over time not only will fewer people contribute to the fund but the actual increase in the number...
View full press release